The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The average one-year price target for PACS Group (NYSE:PACS) has been revised to $27.88 / share. This is a decrease of 17.17% from the prior estimate of $33.66 dated September 27, 2025. The price ...

The average one-year price target for PACS Group (NYSE:PACS) has been revised to $40.63 / share. This is an increase of 10.14% from the prior estimate of $36.89 dated December 18, 2025. The price ...

PACS Group demonstrates strong operational momentum, with gross and operating margins reaching 18.3% and 9.7%, respectively. PACS is expanding aggressively, acquiring 34 new facilities and projecting ...

Utah-based Crewe Advisors disclosed the acquisition of 1,035,747 shares of PACS Group (NYSE:PACS) in a January 16 SEC filing, with an estimated transaction value of $22.72 million based on quarterly ...

For 2026, PACS expects revenue in the range of $5.65 billion to $5.75 billion, with a midpoint of $5.7 billion, representing nearly 8% growth over 2025. Adjusted EBITDA is projected to be between $555 ...

Investors interested in stocks from the Medical Services sector have probably already heard of PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two stocks presents investors with the ...

Investors with an interest in Medical Services stocks have likely encountered both PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?

Utah-based Crewe Advisors bought 1,035,747 PACS shares in the fourth quarter for an estimated $22.72 million. Meanwhile, the quarter-end PACS position value rose by $67.19 million, reflecting both ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...